Management of Strep-Positive Individuals Without Symptoms
Asymptomatic individuals who test positive for group A streptococci do not require antibiotic treatment as they are likely carriers who are at low risk for developing complications and are unlikely to spread the organism to close contacts. 1
Understanding Streptococcal Carriers
- Streptococcal carriers have group A β-hemolytic streptococci present in their pharynx but show no evidence of immunologic response to the organism 1
- During winter and spring in temperate climates, up to 20% of asymptomatic school-aged children may be streptococcal carriers 1, 2
- Carriers are at low risk, if any, for developing suppurative complications (e.g., peritonsillar abscess) or nonsuppurative complications (e.g., acute rheumatic fever) 1
- Carriers are unlikely to spread the organism to their close contacts 1, 2
Rationale for Not Treating Asymptomatic Carriers
- It is more difficult to eradicate group A streptococci from the upper respiratory tracts of streptococcal carriers compared to those with acute infection 1
- Many published studies showing high rates of failure to eradicate group A streptococci with penicillin therapy likely included carriers 1
- The Infectious Diseases Society of America (IDSA) guidelines clearly state that routine culture or treatment of asymptomatic individuals is not recommended 1, 2
- Follow-up throat cultures are not routinely indicated for asymptomatic patients who have received a complete course of therapy for group A streptococcal pharyngitis 1
Special Circumstances When Treatment May Be Considered
Treatment of asymptomatic carriers may be considered in specific situations:
- During a community outbreak of acute rheumatic fever, acute poststreptococcal glomerulonephritis, or invasive GAS infection 1
- During an outbreak of GAS pharyngitis in a closed or partially closed community 1
- In the presence of a family or personal history of acute rheumatic fever 1
- In a family with excessive anxiety about GAS infections 1
- When tonsillectomy is being considered only because of carriage 1
Treatment Regimens for Carriers When Indicated
When treatment of carriers is deemed necessary, the following regimens have been shown to be more effective than penicillin or amoxicillin:
- Oral clindamycin: 20–30 mg/kg/day in 3 doses (max = 300 mg/dose) for 10 days 1
- Penicillin V with rifampin: Penicillin V for 10 days plus rifampin for the last 4 days of treatment 1
- Amoxicillin–clavulanic acid: 40 mg amoxicillin/kg/day in 3 doses for 10 days 1
- Intramuscular benzathine penicillin G with oral rifampin: One dose of benzathine penicillin G plus rifampin for 4 days 1
Distinguishing Carriers from Acute Infection
- Helpful clues to differentiate carriers with intercurrent viral infections from patients with acute streptococcal pharyngitis include:
Common Pitfalls
- Treating all strep-positive individuals regardless of symptoms can lead to unnecessary antibiotic use, contributing to antimicrobial resistance 1, 2
- Treating carriers may not eradicate the organism and can give false reassurance 1
- Attempting to eradicate carriage through repeated courses of antibiotics is generally unsuccessful and not recommended 1
- Misinterpreting a positive test in an asymptomatic individual as requiring treatment, when they are likely just carriers 2